These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24349246)

  • 1. The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
    Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutiérrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; VanMeurs JC; González-Sarmiento R; Pastor JC;
    PLoS One; 2013; 8(12):e82283. PubMed ID: 24349246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.
    Pastor-Idoate S; Rodriguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; van Meurs J; González-Sarmiento R; Pastor JC;
    Ophthalmology; 2013 Mar; 120(3):623-628. PubMed ID: 23207172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.
    Zhou G; Duan Y; Ma G; Wu W; Hu Z; Chen N; Chee Y; Cui J; Samad A; Matsubara JA; Mukai S; D'Amore PA; Lei H
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5361-5367. PubMed ID: 29049737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project.
    Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon YD; Harsum S; MacLaren RE; Charteris DG; Van Meurs JC; González-Sarmiento R; Pastor JC;
    Acta Ophthalmol; 2015 Nov; 93(7):e541-9. PubMed ID: 25991504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASSOCIATION STUDY BETWEEN POLYMORPHISMS OF THE p53 AND LYMPHOTOXIN ALPHA (LTA) GENES AND THE RISK OF PROLIFERATIVE VITREORETINOPATHY/RETINAL DETACHMENT IN A MEXICAN POPULATION.
    Quiroz-Casian N; Lozano-Giral D; Miranda-Duarte A; Garcia-Montalvo I; Rodriguez-Loaiza JL; Zenteno JC
    Retina; 2018 Jan; 38(1):187-191. PubMed ID: 28106707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs.
    Thurow HS; Hartwig FP; Alho CS; Silva DS; Roesler R; Abujamra AL; de Farias CB; Brunetto AL; Horta BL; Dellagostin OA; Collares T; Seixas FK
    Mol Biol Rep; 2013 Aug; 40(8):4929-34. PubMed ID: 23661019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis.
    Cai X; Yang M
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):555-61. PubMed ID: 22205265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population.
    Yilmaz M; Tas A; Donmez G; Kacan T; Silig Y
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1059-1062. PubMed ID: 29699057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of
    Sivonova MK; Jurecekova J; Kaplan P; Hives M; Grendar M; Tomascova A; Dusenka R; Drobkova H; Evin D; Kliment J
    Anticancer Res; 2020 Nov; 40(11):6257-6264. PubMed ID: 33109563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
    Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
    Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
    Wan Y; Wu W; Yin Z; Guan P; Zhou B
    BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome.
    Assmann G; Wagner AD; Monika M; Pfoehler C; Pfreundschuh M; Tilgen W; Roemer K
    Rheumatol Int; 2010 Aug; 30(10):1273-6. PubMed ID: 19779722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The
    Jiang H; Yan B; Meng Z; Zhang L; Lei H; Luo J
    Front Cell Dev Biol; 2022; 10():841660. PubMed ID: 35359434
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
    Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
    DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells.
    Duan Y; Ma G; Huang X; D'Amore PA; Zhang F; Lei H
    J Biol Chem; 2016 Jul; 291(31):16339-47. PubMed ID: 27246850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ID genotype of MDM2 40 bp insertion/deletion polymorphism was associated with lower risk of SLE.
    Salimi S; Rezaei M; Mohammadpour-Gharehbagh A; Sajadian M; Sandoughi M
    Postgrad Med J; 2017 Dec; 93(1106):758-761. PubMed ID: 28676527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53 G72C and MDM2 T309G single nucleotide polymorphisms in patients with Wegener's granulomatosis.
    Assmann G; Wieczorek S; Wibisono D; Roemer K; Arning L; Voswinkel J
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S72-5. PubMed ID: 18799058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
    Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
    BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.